Search Results

A man stands before a group, giving a presentation while the audience listens intently in a meeting room.
MedBound Blog

IISc Bengaluru Develops Low-Cost Paper Sensor for Early Liver Cancer Detection

Sakshi Thakar
2 min read
Researchers at IISc Bengaluru have created an affordable, paper-based glowing sensor that detects liver cancer biomarkers using terbium's green luminescence.
Histological section of an FLC tumor, showing the stromal (left), normal (center), and tumor (right) cells. The colors correspond to gene markers identified for different cell types.
Medicine

Unique Characteristics of a Rare Liver Cancer Identified as Clinical Trial of New Treatment Begins

MBT Desk
4 min read
This recent study shows unique set of genes in rare cancer of the liver helps understand cancer treatment in a better way
Liver Cancer (Pexels)
Medicine

Steps You Can Take to Reduce Your Risk for Liver Cancer

MBT Desk
2 min read
Liver cancer is the sixth leading cause of cancer death in the U.S.
New Study Reveals How Gender Affects Liver Transplant Success in Cancer Patients
Medicine

New Study Reveals How Gender Affects Liver Transplant Success in Cancer Patients

MBT Desk
2 min read
Recent research suggests that female patients may fare better after transplant, indicating a potential need to reassess organ allocation practices for greater fairness and improved care.
When treating liver cancer, the goal extends beyond eradicating the disease; it involves enhancing the patient's overall quality of life (QOL). (Unsplash)
Fitness and Wellness

Prioritizing Patient Well-Being: A Multifaceted Approach to QOL Management in Liver Cancer

MBT Desk
5 min read
Guide: Strategies balance treatment & quality of life for liver cancer patients. Understanding its impact vital for holistic care.
A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients i.e. patients with liver cancer (Pixabay)
Medicine

Combined Therapy Makes Headway for Liver Cancer

MBT Desk
3 min read
Adding another drug to immunotherapy increased the response rate for hepatocellular carcinoma (cancer) patients in the phase 2 trial, UTSW reports
Read More
logo
Medbound
www.medboundtimes.com